Skip to search formSkip to main contentSkip to account menu

Discontinuation (procedure)

Known as: discontinuation, discontinuations 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
BACKGROUND Sunitinib, a vascular endothelial growth factor pathway inhibitor, is an effective treatment for metastatic renal-cell… 
Highly Cited
2016
Highly Cited
2016
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
Highly Cited
2015
Highly Cited
2015
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
BACKGROUND The combination of daclatasvir, a hepatitis C virus (HCV) NS5A inhibitor, and the NS5B inhibitor sofosbuvir has shown… 
Highly Cited
2013
Highly Cited
2013
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
BACKGROUND Several antiretroviral agents (ARVs) are associated with chronic renal impairment, but the extent of such adverse… 
Highly Cited
2011
Highly Cited
2011
Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Sclerostin, an osteocyte‐secreted protein, negatively regulates osteoblasts and inhibits bone formation. In this first‐in‐human… 
Highly Cited
2007
Highly Cited
2007
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
OBJECTIVE To assess the efficacy and safety of aripiprazole versus placebo as adjunctive treatment to standard antidepressant… 
Highly Cited
2007
Highly Cited
2007
Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1–infected slow responders
In hepatitis C virus (HCV) genotype 1 infection, the duration of interferon‐based therapy is a critical determinant in achieving… 
Highly Cited
2006
Highly Cited
2006
Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.
OBJECTIVE The objective of this study was to compare the efficacy and safety of the moderate-affinity, uncompetitive N-methyl-d… 
Highly Cited
2005
Highly Cited
2005
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.
Highly Cited
1998
Highly Cited
1998
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
OBJECTIVES To determine the clinical effect of oral montelukast sodium, a leukotriene receptor antagonist, in asthmatic patients… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)